4//SEC Filing
Wedell-Wedellsborg Johan 4
Accession 0001415889-25-019048
CIK 0001722964other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:20 PM ET
Size
8.7 KB
Accession
0001415889-25-019048
Insider Transaction Report
Form 4
Wedell-Wedellsborg Johan
Director10% Owner
Transactions
- Award
Common Stock
2025-06-30+25,080→ 30,905 total - Award
Employee Stock Option (right to buy)
2025-06-30+33,450→ 33,450 totalExercise: $4.51Exp: 2035-06-30→ Common Stock (33,450 underlying)
Holdings
- 4,559,233(indirect: By WG Biotech ApS)
Common Stock
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock on the vesting date of the RSUs. The RSUs vest in full on the earlier of the first anniversary of the date of grant or the date immediately preceding the date of the Issuer's annual meeting of stockholders held in 2026, subject to the Reporting Person's continued service to the Issuer on the vesting date.
- [F2]Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.
- [F3]Stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F4]The stock options vest in equal monthly installments until the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer on each vesting date, and are exercisable immediately upon vesting.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001753185
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:20 PM ET
- Size
- 8.7 KB